Cure My Disease

Don't miss your cure!

 Log in / Sign up

Structured diabetes program aims to help patients take control of blood sugar

NCT ID NCT06719076

Disease control Sponsor: Health Services Academy, Islamabad, Pakistan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 17, 2026 · Updated 4 times

Summary

This study tests whether a structured Diabetes Healthcare Program can help adults with type 2 diabetes improve their blood sugar control and feel more confident managing their condition. Participants attend six biweekly training sessions covering diet, exercise, medication, and stress management. Researchers compare blood sugar levels and self-care confidence between those in the program and those receiving standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Diabetes Healthcare Program (structured education and lifestyle coaching)
What this could lead to
If effective, this program could offer a low-cost, scalable way to help people with type 2 diabetes better manage their blood sugar and daily self-care.
What could go wrong
This is a small, single-site trial with 128 participants, so results may not apply broadly. The program requires regular attendance and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

128 people

The number who actually took part.

Started

Aug 2024

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Type-II Diabetes on follow-up treatment in FGH for last 6 months. * Type-II Diabetic age 18 years and above of both genders. * Type-II Diabetic with uncontrolled Diabetes whose HbA1c reading is \>6.4% at last assessment within 3 months * Type-II Diabetic living in Islamabad. Exclusion Criteria: * Type-II Diabetic recognized as disabled and suffering from loss of hearing. * Type-II Diabetics with serious complications such as retinopathy/kidney disease/tachycardia in a stable status \> 100/minute, or serious diabetic feet * Type-II Diabetic currently using injection insulin impaired glucose tolerance, metabolic syndrome, maturity onset diabetes of youth and gestational diabetes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes knowledge are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus glucose metabolism disease type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes knowledge HbA1c Self efficacy

Contacts and locations

Locations

  • Federal General Hospital

    Islamabad, ICT, 44000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.